Form 4: Oscar Health Director David Plouffe Reports Acquisition of Restricted Stock Units

Oscar Health, Inc. Director David Plouffe has reported the acquisition of 14,134 Class A Common Stock restricted stock units (RSUs) on June 4, 2025, increasing his total beneficial ownership to 128,646 shares.

Summary

• David Plouffe, a Director of Oscar Health, Inc. (OSCR), acquired 14,134 Class A Common Stock restricted stock units (RSUs) on June 4, 2025.
• These RSUs were acquired at a price of $0.00, indicating they were a grant as part of compensation.
• Following this transaction, Mr. Plouffe's direct beneficial ownership of Class A Common Stock is 128,646 shares.
• Each RSU represents a contingent right to receive one share of Oscar Health, Inc. Class A common stock.
• The RSUs vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders, subject to continued service through the applicable vesting date.
• Vested RSUs will be settled in shares upon the earliest of six months after separation from service, death, disability, or within five days following a change in control of the Issuer.

Sentiment

Score: 7

Explanation: The acquisition of RSUs by a director is generally a positive signal as it aligns insider interests with shareholder value, indicating continued commitment to the company's long-term success. It's a routine compensation event, not a major strategic announcement, hence a moderately positive score.

Positives

• Director David Plouffe's acquisition of 14,134 restricted stock units (RSUs) aligns his interests with shareholders, as the value of these units is tied to the company's stock performance.
• The grant of RSUs at a $0.00 price is a common form of equity compensation, indicating ongoing commitment and incentivization for the director.

Risks

• The value of the restricted stock units (RSUs) is subject to the future performance of Oscar Health, Inc.'s Class A common stock.
• Vesting of the RSUs is contingent upon David Plouffe's continued service to the company.

Future Outlook

The vesting schedule for the restricted stock units (RSUs) indicates a future commitment from Director David Plouffe, with vesting occurring on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, subject to continued service. Settlement of vested RSUs is tied to future events such as separation from service or a change in control.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity grant within the healthcare technology and insurance industry. Such grants are common practice for incentivizing directors and aligning their interests with long-term shareholder value, reflecting standard corporate governance practices across various sectors, including healthcare.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) to a director at a $0.00 price is a standard form of equity compensation in publicly traded companies, including those in the healthcare and technology sectors.
• Companies like UnitedHealth Group (UNH), Anthem (ELV), and Cigna (CI) also utilize RSU grants as part of their executive and director compensation packages to promote long-term alignment and retention.
• The vesting conditions (time-based and service-based) are typical for such awards across the industry, ensuring continued commitment from the director.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns management's interests with shareholders, as the value of the compensation is directly tied to the company's stock performance.

Next Steps

• The restricted stock units (RSUs) granted on June 4, 2025, will vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders, subject to David Plouffe's continued service.
• Vested RSUs will be settled in shares of Class A common stock upon the earliest of six months after separation from service, death, disability, or within five days following a change in control of Oscar Health, Inc.

Key Dates

Keywords

Oscar Health, OSCR, Form 4, SEC filing, insider transaction, restricted stock units, RSUs, beneficial ownership, director compensation, equity compensation